|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Current Assets | ||||||||||||||||||||
| Cash and Cash Equivalents | ||||||||||||||||||||
| Accounts Receivable (Less Allowance of $1.6 and $1.6) | ||||||||||||||||||||
| Accounts Receivable (Less Allowance of $1.7 and $1.7) | ||||||||||||||||||||
| Inventories – Net | ||||||||||||||||||||
| Prepayments and Other | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Property, Plant and Equipment – Net | ||||||||||||||||||||
| Regulatory Assets | ||||||||||||||||||||
| Equity Investments | ||||||||||||||||||||
| Goodwill and Intangible Assets – Net | ||||||||||||||||||||
| Other Non-Current Assets | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| Liabilities, Redeemable Non-Controlling Interest and Equity | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Current Liabilities | ||||||||||||||||||||
| Accounts Payable | ||||||||||||||||||||
| Accrued Taxes | ||||||||||||||||||||
| Accrued Interest | ||||||||||||||||||||
| Long-Term Debt Due Within One Year | ||||||||||||||||||||
| Other | ||||||||||||||||||||
| Total Current Liabilities | ||||||||||||||||||||
| Long-Term Debt | ||||||||||||||||||||
| Deferred Income Taxes | ||||||||||||||||||||
| Regulatory Liabilities | ||||||||||||||||||||
| Defined Benefit Pension and Other Postretirement Benefit Plans | ||||||||||||||||||||
| Other Non-Current Liabilities | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Redeemable Non-Controlling Interest | ||||||||||||||||||||
| Equity | ||||||||||||||||||||
| ALLETE Equity | ||||||||||||||||||||
| Common Stock Without Par Value, 80.0 Shares Authorized, 58.1 and 57.9 Shares Issued and Outstanding | ||||||||||||||||||||
| Accumulated Other Comprehensive Loss | ||||||||||||||||||||
| Retained Earnings | ||||||||||||||||||||
| Total ALLETE Equity | ||||||||||||||||||||
| Non-Controlling Interest in Subsidiaries | ||||||||||||||||||||
| Total Equity | ||||||||||||||||||||
| Total Liabilities, Redeemable Non-Controlling Interest and Equity |
Loading...
